⌘K
t
GSK plc confirmed its name has changed from GlaxoSmithKline plc to GSK plc. The Company announced this decision on 27 April 2022, and the change took effect today, 16 May 2022. The ISINs, SEDOLs, CUSIPs, ticker symbols, and Legal Entity Identifier (5493000HZTVUYLO1D793) remain unchanged, and shareholdings are unaffected.
| Date | 16 May 2022 |
| Time | 14:00:03 |
| Category | Corporate updates |
| ID | 6484L |
GSK plc
(the 'Company')
Change of name to GSK plc
The Company today confirms its name has changed from GlaxoSmithKline plc to GSK plc.
The Company announced the decision to change its name to GSK plc on 27 April 2022 together with its first quarter 2022 results. This change has now taken effect.
The London Stock Exchange and the New York Stock Exchange will reflect the change of name in due course.
Shareholders should note that their shareholdings will be unaffected by the change of name. Existing share certificates should be retained as they will remain valid for all purposes and no new share certificates will be issued.
The ISINs, SEDOLs, CUSIPs and ticker symbols of the Company's ordinary shares and ADS remain unchanged. The Company's Legal Entity Identifier (LEI) remains 5493000HZTVUYLO1D793.
V A Whyte
Company Secretary
16 May 2022